Biotech Growth Trust plc (The) (BIOG) Ordinary 25p

- Add to watchlist
- Create an alert
- This stock can be held in a




720.00p
744.00p
1,068.00p
790.85
740.00p
720.00p
616.00p
-7.19%
6.00p (0.82%) Previous:
6.00p
95,011
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 8.19% | 1 year 1Y | 21.02% |
---|---|---|---|
1 month 1M | 3.14% | 2 years 2Y | 5.97% |
3 months 3M | 15.72% | 3 years 3Y | 12.53% |
6 months 6M | 28.16% | 5 years 5Y | 27.02% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | NASDAQ Biotechnology TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | Yes |
Ongoing charge: | 1.20% |
Dividend yield: | n/a |
Dividend frequency: | None |
Total assets: | £213m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £197m |
Shares in issue: | 26.84 million |
Legal structure | Closed Ended Investment Company |
Domicile: | United Kingdom |
ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 790.85p |
---|---|
Latest actual NAV: | 795.50p |
Latest actual NAV date: | 24 April 2025 |
Premium/Discount: | -7.19% |
12m average Premium/Discount: | -8.40% |
NAV frequency: | Daily |
Security | Weight |
---|---|
Neurocrine Biosciences Inc | 7.33% |
Gilead Sciences Inc | 6.15% |
Sarepta Therapeutics Inc | 6.07% |
Ionis Pharmaceuticals Inc | 5.28% |
Alnylam Pharmaceuticals Inc | 5.25% |
Argen X SE EUR0.10 | 5.16% |
Intra-Cellular Therapies Inc | 3.69% |
Dyne Therapeutics Inc Ordinary Shares | 3.41% |
Xenon Pharmaceuticals Inc | 3.39% |
Vera Therapeutics Inc Class A | 3.18% |
Sector | Weight |
---|---|
Healthcare | 104.88% |
Country | Weight |
---|---|
United States | 93.96% |
China | 6.41% |
Canada | 4.74% |
Germany | 1.39% |
Switzerland | 1.15% |
Key Dates
Launch date: | 23 June 1997 |
---|---|
Financial year end: | March |
Next AGM: | July 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.